How do today’s biotech companies cultivate innovation and harness digital tools for strategic growth? In this episode, we dissect the pivotal role that digital enterprise capabilities play in transforming a company's approach to challenges in the life sciences sector.As I chat with Matt Lasmanis, Chief Technology & Innovation Officer at Sage Therapeutics, we delve into the transformative power of technology within the biotech industry. Matt shares his invaluable insights on strengthening a company's data strategy, investing in AI, and integrating advanced analytics to drive informed decisions. We're exploring the notable shift from the traditional IT department to a model that embodies digital and enterprise capabilities, underlining how crucial this evolution is for a company like Sage. Matt's insights on the cultural shift within the biotech industry and the necessity of a growth mindset promise to be enlightening for leaders and innovators alike.This episode is a must-listen for anyone looking to understand how strategic digital transformation positions a company at the forefront of innovation. Rediscover the potential within the biotech industry by tuning into our engaging conversation.Specifically, this episode highlights the following themes:The strategic implementation of data analytics and AI within Sage TherapeuticsNurturing a culture of innovation within life sciences companiesThe strategic role of cybersecurity and privacy in technology investment decisionsLinks from this episode:Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupGet to know more about Matt Lasmanis: https://www.linkedin.com/in/mattlasmanisLearn more about Sage Therapeutics: https://www.sagerx.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related